Literature DB >> 20427532

Exchange of the coronavirus replicase polyprotein cleavage sites alters protease specificity and processing.

Mark J Gadlage1, Mark R Denison.   

Abstract

Coronavirus nonstructural proteins 1 to 3 are processed by one or two papain-like proteases (PLP1 and PLP2) at specific cleavage sites (CS1 to -3). Murine hepatitis virus (MHV) PLP2 and orthologs recognize and cleave at a position following a p4-Leu-X-Gly-Gly-p1 tetrapeptide, but it is unknown whether these residues are sufficient to result in processing by PLP2 at sites normally cleaved by PLP1. We demonstrate that exchange of CS1 and/or CS2 with the CS3 p4-p1 amino acids in engineered MHV mutants switches specificity from PLP1 to PLP2 at CS2, but not at CS1, and results in altered protein processing and virus replication. Thus, the p4-p1 residues are necessary for PLP2 processing but require a specific protein or cleavage site context for optimal PLP recognition and cleavage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20427532      PMCID: PMC2903247          DOI: 10.1128/JVI.00752-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  Virus-encoded proteinases and proteolytic processing in the Nidovirales.

Authors:  J Ziebuhr; E J Snijder; A E Gorbalenya
Journal:  J Gen Virol       Date:  2000-04       Impact factor: 3.891

2.  Identification of a novel cleavage activity of the first papain-like proteinase domain encoded by open reading frame 1a of the coronavirus Avian infectious bronchitis virus and characterization of the cleavage products.

Authors:  K P Lim; L F Ng; D X Liu
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Coronavirus protein processing and RNA synthesis is inhibited by the cysteine proteinase inhibitor E64d.

Authors:  J C Kim; R A Spence; P F Currier; X Lu; M R Denison
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

4.  Identification of mouse hepatitis virus papain-like proteinase 2 activity.

Authors:  A Kanjanahaluethai; S C Baker
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China.

Authors: 
Journal:  Science       Date:  2004-01-29       Impact factor: 47.728

6.  Mouse hepatitis virus replicase proteins associate with two distinct populations of intracellular membranes.

Authors:  A C Sims; J Ostermann; M R Denison
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59.

Authors:  Boyd Yount; Mark R Denison; Susan R Weiss; Ralph S Baric
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  The autocatalytic release of a putative RNA virus transcription factor from its polyprotein precursor involves two paralogous papain-like proteases that cleave the same peptide bond.

Authors:  J Ziebuhr; V Thiel; A E Gorbalenya
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

Review 9.  Coronaviruses post-SARS: update on replication and pathogenesis.

Authors:  Stanley Perlman; Jason Netland
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

10.  Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.

Authors:  Eric J Snijder; Peter J Bredenbeek; Jessika C Dobbe; Volker Thiel; John Ziebuhr; Leo L M Poon; Yi Guan; Mikhail Rozanov; Willy J M Spaan; Alexander E Gorbalenya
Journal:  J Mol Biol       Date:  2003-08-29       Impact factor: 5.469

View more
  11 in total

1.  Temperature-sensitive mutants and revertants in the coronavirus nonstructural protein 5 protease (3CLpro) define residues involved in long-distance communication and regulation of protease activity.

Authors:  Christopher C Stobart; Alice S Lee; Xiaotao Lu; Mark R Denison
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  Dissection of amino-terminal functional domains of murine coronavirus nonstructural protein 3.

Authors:  Kelley R Hurst-Hess; Lili Kuo; Paul S Masters
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

3.  Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex.

Authors:  Kelley R Hurst; Cheri A Koetzner; Paul S Masters
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

4.  Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation.

Authors:  Megan Culler Freeman; Rachel L Graham; Xiaotao Lu; Christopher T Peek; Mark R Denison
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

5.  Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CLpro targeting repurposed drug candidates.

Authors:  Nitin Chitranshi; Vivek K Gupta; Rashi Rajput; Angela Godinez; Kanishka Pushpitha; Ting Shen; Mehdi Mirzaei; Yuyi You; Devaraj Basavarajappa; Veer Gupta; Stuart L Graham
Journal:  J Transl Med       Date:  2020-07-09       Impact factor: 5.531

6.  Discovery and Characterization of Novel RNA Viruses in Aquatic North American Wild Birds.

Authors:  Marta Canuti; Ashley N K Kroyer; Davor Ojkic; Hugh G Whitney; Gregory J Robertson; Andrew S Lang
Journal:  Viruses       Date:  2019-08-21       Impact factor: 5.048

7.  The time to offer treatments for COVID-19.

Authors:  Binh T Ngo; Paul Marik; Pierre Kory; Leland Shapiro; Raphael Thomadsen; Jose Iglesias; Stephen Ditmore; Marc Rendell; Joseph Varon; Michael Dubé; Neha Nanda; Gino In; Daniel Arkfeld; Preet Chaudhary; Vito M Campese; Diana L Hanna; David E Sawcer; Glenn Ehresmann; David Peng; Miroslaw Smogorewski; April Armstrong; Rajkumar Dasgupta; Fred Sattler; Denise Brennan-Rieder; Cristina Mussini; Oriol Mitja; Vicente Soriano; Nicolas Peschanski; Gilles Hayem; Marco Confalonieri; Maria Carmela Piccirillo; Antonio Lobo-Ferreira; Iraldo Bello Rivero; Mika Turkia; Eivind H Vinjevoll; Daniel Griffin; Ivan Fn Hung
Journal:  Expert Opin Investig Drugs       Date:  2021-04-23       Impact factor: 6.206

8.  Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery.

Authors:  Maria Yu Zakharova; Alexandra A Kuznetsova; Victoria I Uvarova; Anastasiia D Fomina; Liubov I Kozlovskaya; Elena N Kaliberda; Inna N Kurbatskaia; Ivan V Smirnov; Anatoly A Bulygin; Vera D Knorre; Olga S Fedorova; Alexandre Varnek; Dmitry I Osolodkin; Aydar A Ishmukhametov; Alexey M Egorov; Alexander G Gabibov; Nikita A Kuznetsov
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

Review 9.  [Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination].

Authors:  J Reina; C Iglesias
Journal:  Rev Esp Quimioter       Date:  2022-02-21       Impact factor: 2.515

10.  A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.

Authors:  Maren de Vries; Adil S Mohamed; Rachel A Prescott; Ana M Valero-Jimenez; Ludovic Desvignes; Rebecca O'Connor; Claire Steppan; Joseph C Devlin; Ellie Ivanova; Alberto Herrera; Austin Schinlever; Paige Loose; Kelly Ruggles; Sergei B Koralov; Annaliesa S Anderson; Joseph Binder; Meike Dittmann
Journal:  J Virol       Date:  2021-02-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.